Literature DB >> 34550497

Protein Production and Purification of a Codon-Optimized Human NGN3 Transcription Factor from E. coli.

Gloria Narayan1, Akriti Agrawal1, Neha Joshi2, Ranadeep Gogoi3,4, Shirisha Nagotu2, Rajkumar P Thummer5.   

Abstract

Neurogenin 3 (NGN3) transcription factor is vital for the development of endocrine cells of the intestine and pancreas. NGN3 is also critical for the neural precursor cell determination in the neuroectoderm. Additionally, it is one of the vital transcription factors for deriving human β-cells from specialized somatic cells. In the current study, the production and purification of the human NGN3 protein from Escherichia coli (E. coli) is reported. First, the 642 bp protein-coding nucleotide sequence of the NGN3 gene was codon-optimized to enable enhanced protein expression in E. coli strain BL21(DE3). The codon-optimized NGN3 sequence was fused in-frame to three different fusion tags to enable cell penetration, nuclear translocation, and affinity purification. The gene insert with the fusion tags was subsequently cloned into an expression vector (pET28a( +)) for heterologous expression in BL21(DE3) cells. A suitable genetic construct and the ideal expression conditions were subsequently identified that produced a soluble form of the recombinant NGN3 fusion protein. This NGN3 fusion protein was purified to homogeneity (purity > 90%) under native conditions, and its secondary structure was retained post-purification. This purified protein, when applied to human cells, did not induce cytotoxicity. Further, the cellular uptake and nuclear translocation of the NGN3 fusion protein was demonstrated followed by its biological activity in PANC-1 cells. Prospectively, this recombinant protein can be utilized for various biological applications to investigate its functionality in cell reprogramming, biological processes, and diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  BL21(DE3); E. coli; NGN3; Protein expression and purification; Recombinant protein; Secondary structure

Mesh:

Substances:

Year:  2021        PMID: 34550497     DOI: 10.1007/s10930-021-10020-x

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  48 in total

1.  Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors.

Authors:  Hui Zhang; Yu Ma; Junjie Gu; Bing Liao; Jiwen Li; Jiemin Wong; Ying Jin
Journal:  Biomaterials       Date:  2012-04-09       Impact factor: 12.479

2.  A Comprehensive Structure-Function Study of Neurogenin3 Disease-Causing Alleles during Human Pancreas and Intestinal Organoid Development.

Authors:  Xinghao Zhang; Patrick S McGrath; Joseph Salomone; Mohamed Rahal; Heather A McCauley; Jamie Schweitzer; Rhett Kovall; Brian Gebelein; James M Wells
Journal:  Dev Cell       Date:  2019-06-06       Impact factor: 12.270

Review 3.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

4.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas.

Authors:  G Gradwohl; A Dierich; M LeMeur; F Guillemot
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 5.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

Review 6.  Advances in recombinant protein expression for use in pharmaceutical research.

Authors:  Rene Assenberg; Paul T Wan; Sabine Geisse; Lorenz M Mayr
Journal:  Curr Opin Struct Biol       Date:  2013-06-01       Impact factor: 6.809

7.  Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3.

Authors:  Oscar Rubio-Cabezas; Jan N Jensen; Maria I Hodgson; Ethel Codner; Sian Ellard; Palle Serup; Andrew T Hattersley
Journal:  Diabetes       Date:  2011-03-04       Impact factor: 9.461

8.  The window period of NEUROGENIN3 during human gestation.

Authors:  Rachel J Salisbury; Jennifer Blaylock; Andrew A Berry; Rachel E Jennings; Ronald De Krijger; Karen Piper Hanley; Neil A Hanley
Journal:  Islets       Date:  2014       Impact factor: 2.694

Review 9.  Recombinant protein expression in Escherichia coli: advances and challenges.

Authors:  Germán L Rosano; Eduardo A Ceccarelli
Journal:  Front Microbiol       Date:  2014-04-17       Impact factor: 5.640

10.  Neurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate.

Authors:  Danielle L Gomez; Marci O'Driscoll; Timothy P Sheets; Ralph H Hruban; Jose Oberholzer; James J McGarrigle; Michael J Shamblott
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more
  1 in total

1.  Generation of a recombinant version of a biologically active cell-permeant human HAND2 transcription factor from E. coli.

Authors:  Krishna Kumar Haridhasapavalan; Pradeep Kumar Sundaravadivelu; Neha Joshi; Nayan Jyoti Das; Anshuman Mohapatra; Udayashree Voorkara; Vishwas Kaveeshwar; Rajkumar P Thummer
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.